Drugs / Tenofovir Disoproxil Fumurate
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03916328 Comparator | Dec 2019 → Mar 2024 | bone resorption disease | MU-JHU CARE | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tenofovir Disoproxil Fumurate | “A third of the women will remain on Tenofovir Disoproxil Fumurate.(TDF) containing ART.” NCT03916328 ↗ |
| Known as | TDF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03916328 ↗ |